Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
It is intended to be used as adjunctive therapy in addition to nutrition support or health coaching from a qualified professional
doi: 10.1158/1055-9965.EPI-20-0743 118 SouleSKingJAMillarRP
Clinically, the ATTAIN Phase 3 program showed that orforglipron at its highest dose delivered a mean weight loss of 12.4% over 72 weeks, slightly less than the WEGOVY pills 13.6% at 64 weeks, but with a broader, more diverse patient population of over 3,000 participants
10.1177/107155769600300207 42 RotweinP
This study aims to add to the literature to inform future strategies to improve long-term adherence and support patients in reaching their treatment goals
US$ 23.37
US$ 28.50
US$ 23.45
US$ 26.45
US$ 26.47
US$ 20.85
US$ 28.93
US$ 29.80
